HUTCHMED (China) Statistics
Total Valuation
HCM has a market cap or net worth of $1.80 billion. The enterprise value is $566.52 million.
| Market Cap | 1.80B |
| Enterprise Value | 566.52M |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HCM has 859.74 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 859.74M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 0.98% |
| Owned by Institutions (%) | 19.47% |
| Float | 508.44M |
Valuation Ratios
The trailing PE ratio is 3.95 and the forward PE ratio is 35.31.
| PE Ratio | 3.95 |
| Forward PE | 35.31 |
| PS Ratio | 3.29 |
| Forward PS | 2.70 |
| PB Ratio | 1.44 |
| P/TBV Ratio | 1.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 1.24 |
| EV / Sales | 1.03 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.96, with a Debt / Equity ratio of 0.08.
| Current Ratio | 4.96 |
| Quick Ratio | 4.81 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.67 |
Financial Efficiency
Return on equity (ROE) is 45.25% and return on invested capital (ROIC) is -1,741.75%.
| Return on Equity (ROE) | 45.25% |
| Return on Assets (ROA) | -1.62% |
| Return on Invested Capital (ROIC) | -1,741.75% |
| Return on Capital Employed (ROCE) | -2.72% |
| Weighted Average Cost of Capital (WACC) | 6.08% |
| Revenue Per Employee | $305,408 |
| Profits Per Employee | $254,404 |
| Employee Count | 1,796 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 10.59 |
Taxes
In the past 12 months, HCM has paid $63.61 million in taxes.
| Income Tax | 63.61M |
| Effective Tax Rate | 12.20% |
Stock Price Statistics
The stock price has decreased by -34.56% in the last 52 weeks. The beta is 0.37, so HCM's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | -34.56% |
| 50-Day Moving Average | 12.71 |
| 200-Day Moving Average | 14.33 |
| Relative Strength Index (RSI) | 28.48 |
| Average Volume (20 Days) | 64,695 |
Short Selling Information
The latest short interest is 209,783, so 0.20% of the outstanding shares have been sold short.
| Short Interest | 209,783 |
| Short Previous Month | 220,392 |
| Short % of Shares Out | 0.20% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.62 |
Income Statement
In the last 12 months, HCM had revenue of $548.51 million and earned $456.91 million in profits. Earnings per share was $0.52.
| Revenue | 548.51M |
| Gross Profit | 63.87M |
| Operating Income | -39.16M |
| Pretax Income | 521.34M |
| Net Income | 456.91M |
| EBITDA | -25.85M |
| EBIT | -39.16M |
| Earnings Per Share (EPS) | $0.52 |
Balance Sheet
The company has $1.37 billion in cash and $97.89 million in debt, with a net cash position of $1.27 billion or $1.48 per share.
| Cash & Cash Equivalents | 1.37B |
| Total Debt | 97.89M |
| Net Cash | 1.27B |
| Net Cash Per Share | $1.48 |
| Equity (Book Value) | 1.25B |
| Book Value Per Share | 1.44 |
| Working Capital | 1.25B |
Cash Flow
In the last 12 months, operating cash flow was -$64.66 million and capital expenditures -$14.15 million, giving a free cash flow of -$78.81 million.
| Operating Cash Flow | -64.66M |
| Capital Expenditures | -14.15M |
| Depreciation & Amortization | 13.31M |
| Net Borrowing | 6.26M |
| Free Cash Flow | -78.81M |
| FCF Per Share | -$0.09 |
Margins
Gross margin is 11.64%, with operating and profit margins of -7.14% and 83.30%.
| Gross Margin | 11.64% |
| Operating Margin | -7.14% |
| Pretax Margin | 95.05% |
| Profit Margin | 83.30% |
| EBITDA Margin | -4.71% |
| EBIT Margin | -7.14% |
| FCF Margin | n/a |
Dividends & Yields
HCM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | n/a |
| Earnings Yield | 25.35% |
| FCF Yield | -4.37% |
Analyst Forecast
The average price target for HCM is $22.83, which is 122.08% higher than the current price. The consensus rating is "Buy".
| Price Target | $22.83 |
| Price Target Difference | 122.08% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 14.46% |
| EPS Growth Forecast (3Y) | -42.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HCM has an Altman Z-Score of 3.9 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.9 |
| Piotroski F-Score | 3 |